Weight loss alone does not fully capture the biochemical adaptations occurring during prolonged GLP-1RA therapy, particularly those related to substrate redistribution, redox balance, and micronutrient-dependent metabolic processes
Eli Lilly, Zepbounds manufacturer, states that Zepbound can cost as little as $25 with insurance, providing a one- to three-month supply
If no previous therapies were tried, the physician must provide a medical rationale (e.g., contraindication or drug interaction)
the long-term data doesnt exist yet, because not enough long-term has happened
If you have mild needle hesitation: Try current injectable medications
B.JanmohamedS.D'AgostinoR